Growing Through Challenges? – Sangamo Therapeutics Inc (SGMO)
Currently, there are 224.71M common shares owned by the public and among those 214.59M shares have been available to trade. The company’s stock has a 5-day price change of 17.59% and -27.98% over the past three months. SGMO shares are trading -27.63% year to date (YTD), with the 12-month market performance up to 35.85% higher. […]
Sangamo Therapeutics Inc (SGMO) Testing Investors’ Patience Right Now
Currently, there are 224.71M common shares owned by the public and among those 214.59M shares have been available to trade. The company’s stock has a 5-day price change of -19.94% and -41.90% over the past three months. SGMO shares are trading -35.64% year to date (YTD), with the 12-month market performance up to 7.62% higher. […]
Sangamo Therapeutics Inc (NASDAQ: SGMO): Hunting Genuine Value In Market Debris
Currently, there are 224.71M common shares owned by the public and among those 214.59M shares have been available to trade. The company’s stock has a 5-day price change of -24.62% and -75.06% over the past three months. SGMO shares are trading -35.71% year to date (YTD), with the 12-month market performance up to 4.98% higher. […]
Following The Money: Institution’s Growing Stake In Sangamo Therapeutics Inc (NASDAQ: SGMO)
Sangamo Therapeutics Inc (SGMO) concluded trading on Wednesday at a closing price of $0.85, with 3.64 million shares of worth about $3.09 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -7.65% during that period and on March 26, 2025 the price saw a […]
Sangamo Therapeutics Inc (NASDAQ: SGMO) – Suitable For Long Term Buy?
Currently, there are 208.62M common shares owned by the public and among those 199.25M shares have been available to trade. The company’s stock has a 5-day price change of -14.70% and -55.70% over the past three months. SGMO shares are trading -17.05% year to date (YTD), with the 12-month market performance up to 8.47% higher. […]
Is There More Upside Ahead For Sangamo Therapeutics Inc (NASDAQ: SGMO)
Sangamo Therapeutics Inc (SGMO) concluded trading on Wednesday at a closing price of $1.00, with 6.18 million shares of worth about $6.18 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 13.22% during that period and on March 12, 2025 the price saw a […]
Better Times Ahead For Sangamo Therapeutics Inc (NASDAQ: SGMO)?
Sangamo Therapeutics Inc (SGMO) concluded trading on Wednesday at a closing price of $0.87, with 4.81 million shares of worth about $4.19 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 3.17% during that period and on March 05, 2025 the price saw a […]
Sangamo Therapeutics Inc (SGMO) Testing Investors’ Patience Right Now
Currently, there are 166.79M common shares owned by the public and among those 154.22M shares have been available to trade. Insiders at the company have transacted a total of 41 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
Handle With Care: Sangamo Therapeutics Inc (NASDAQ: SGMO)
Currently, there are 166.79M common shares owned by the public and among those 154.22M shares have been available to trade. Insiders at the company have transacted a total of 41 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
Sangamo Therapeutics Inc (NASDAQ: SGMO) Stock In Prove Me State
The Vanguard Group, Inc. has recently announced that it has increased stake in Sangamo Therapeutics Inc (NASDAQ:SGMO) by 1.13%. After grabbing 12.41 million shares, the institutional investor is now in possession of 0.14 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.00% having worth around $5.34 million. […]
